Achieving good glycemic control in subjects with T2DM and HF is difficult, as several antihyperglycemic agents have been reported to increase the risk of hospitalization due to HF [43,44,45]
Retatrutide is being studied for potential enhanced weight loss effects, but its long-term safety profile is still under investigation
Heliyon, 10 (15), e35025
The guidance is straightforward: Take the tablet first thing in the morning , before eating or drinking anything Use only a small amount of plain water
Dermatol Ther 33, e13312.CrossRefGoogle ScholarPubMed Sercombe, L, Veerati, T, Moheimani, F, et al
Kim SH, Choi BI, Han MC, Kim YI